Susquehanna Marvell · MRVL

Susquehanna Lowers Marvell Price Target to $300

Analyst: Christopher Rolland 1 min read Reproduced verbatim
Rating
Positive
Target
$300
from $340 (−12%)
Upside
+76%
MRVL at $170 today
Susquehanna and Marvell logos

What the analyst said

Susquehanna analyst Christopher Rolland lowered the price target on Marvell (NASDAQ: MRVL) to $300 (from $340) while maintaining a Positive rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

MRVL trades at $170. The 24 analysts who set a target in the last 3 months range from $175 to $433, with a median of $300. This $300 target is in line with the median.

12-month window: day 1 of 365, closes on November 2, 2027.

Track record

This callOpen: a 12-month target, scored on November 2, 2027, a year after the note.

Firm track recordSusquehanna: 79% of its 14 targets at least a year old were reached within 12 months. Accuracy ranking →

Susquehanna on Marvell

Susquehanna price targets on Marvell

3 calls from August 25, 2026 to November 2, 2026. The target went from $265 to $300 (+13%). The rating stayed Buy.

Susquehanna targetMRVL share price
  1. November 2, 2026 This noteTarget cut from $340 (−12%)Buy$300
  2. October 7, 2026Target raised from $265 (+28%)Buy$340
  3. August 25, 2026Earliest call shownBuy$265
Share

Other analysts on Marvell

Wells FargoBuy Cut price target −22%, kept rating Nov 3 $285from $365 RBC CapitalBuy Cut price target −41%, kept rating Nov 3 $250from $425 NeedhamBuy Cut price target −25%, kept rating Nov 3 $300from $400 Bank of AmericaHold Downgraded, cut price target −44% Nov 3 $225from $400 TD CowenHold Downgraded, cut price target −50% Nov 3 $175from $350
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.